Aarkstore - Metastatic Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
Metastatic Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Metastatic Prostate Cancer. Browse full report @ http://bit.ly/1wdcwzs
Metastatic Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Metastatic Prostate Cancer.
Browse full report @ http://bit.ly/1wdcwzs
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Aarkstore</strong> Enterprise<br />
Please note: This report requires certain updates. We have all the information available but require 3 business<br />
days to complete the process <strong>and</strong> ensure it is as up-to-date as possible. Certain sections in the report may be<br />
removed or altered based on the availability <strong>and</strong> relevance of data for the indicated disease.<br />
Scope<br />
A snapshot of the global Market therapeutics scenario for <strong>Metastatic</strong> <strong>Prostate</strong> <strong>Cancer</strong>.<br />
A review of the marketed products under prescription for <strong>Metastatic</strong> <strong>Prostate</strong> <strong>Cancer</strong>, regulatory<br />
information <strong>and</strong> marketing status.<br />
Coverage of global patent coverage <strong>and</strong> detailed commentaries on the US patent challenges.<br />
Graphical representation of investigational products for patent expiry <strong>and</strong> market exclusivities across<br />
the globe.<br />
Product profiles for marketed products for <strong>Metastatic</strong> <strong>Prostate</strong> <strong>Cancer</strong> with complete description of<br />
mechanism of action, therapeutic class, target, route(s) of administration <strong>and</strong> chemical details.<br />
Coverage of <strong>API</strong> <strong>Manufacturers</strong> for <strong>Metastatic</strong> <strong>Prostate</strong> <strong>Cancer</strong> drugs in the United States, Europe <strong>and</strong><br />
Asian Regions with location details.<br />
Coverage of Regulatory filings in the US, Europe, <strong>and</strong> Asia specifically India <strong>and</strong> China for <strong>Metastatic</strong><br />
<strong>Prostate</strong> <strong>Cancer</strong> drugs.<br />
Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with <strong>Metastatic</strong> <strong>Prostate</strong><br />
<strong>Cancer</strong> drugs.<br />
Coverage of <strong>Metastatic</strong> <strong>Prostate</strong> <strong>Cancer</strong> <strong>Phase</strong> <strong>III</strong> pipeline products featuring sections on product<br />
description, mechanism of action, Chemical details <strong>and</strong> research & development progress.<br />
Coverage of the United States Drug Master File (US DMF) available for <strong>Phase</strong> <strong>III</strong> Pipeline <strong>Drugs</strong>.<br />
Key discontinued <strong>Marketed</strong> products.<br />
<strong>Global</strong> Sales Figure from 2012-2016.<br />
Reasons to buy<br />
<br />
<br />
<br />
Evaluate the marketing status <strong>and</strong> exclusivity details of <strong>Metastatic</strong> <strong>Prostate</strong> <strong>Cancer</strong> key products to<br />
exploit opportunities for generic drug development opportunities.<br />
Identify <strong>and</strong> underst<strong>and</strong> important <strong>and</strong> diverse types of therapeutics under <strong>Phase</strong> <strong>III</strong> development for<br />
<strong>Metastatic</strong> <strong>Prostate</strong> <strong>Cancer</strong>.<br />
Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry<br />
details <strong>and</strong> exclusivity with respect to <strong>Metastatic</strong> <strong>Prostate</strong> <strong>Cancer</strong>.
Change language